PolyNovo Ltd
PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, and Hong Kong. The company offers NovoSorb Biodegradable Temporising Matrix, a dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma, or burn. It is also developing hernia devices for hernia repair and solution for ventral hernia and complex abdominal wall reconstruction; Beta Cell implant, a novel intracutaneous ectopic pancreas to treat type 1 diabetes; NovoSorb MTX for single stage grafting in burns, chronic, and surgical wounds; and plastics and reconstructive device products. The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014. PolyNovo Limited was incorporated in 1998 and is headquartered in Port Melbourne, Australia.
If you'd bought from year…
Same habit, different start year. Each row shows what a constant habit's worth of PNV-AX would be worth today, had you started buying at that point in the asset's history.
| Started | $6/day$6/day coffee | $42/wk$42/week coffee |
|---|---|---|
| Year 1 (1998) — listing | $380,904 9.1× | $550,335 9.1× |
| Year 6 (2003) | $379,435 10.7× | $548,266 10.7× |
| Year 11 (2008) | $350,993 12.6× | $508,201 12.6× |
| Year 16 (2013) | $92,377 4.5× | $133,985 4.6× |
| Year 21 (2018) | $12,123 0.9× | $17,562 1.0× |
| Year 26 (2023) | $4,155 0.8× | $6,017 0.8× |
Repeated investment, no fees, dividends reinvested. $6/day coffee = $180 / month equivalent.
Popular scenarios with PNV
For illustration only — not investment advice. Past performance is not indicative of future results.